Arrowstreet Capital’s CRH Medical Corporation CRHM Stock Holding History

Arrowstreet Capital’s Portfolio CRHM Stock Details CRHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-153,388	Closed	-$357K	–	2671
2020 Q4	$357K	Sell	153,388 -35,806	-19%	-$87.8K	﹤0.01%	2083
2020 Q3	$411K	Buy	189,194 +107,481	+132%	+$251K	﹤0.01%	2072
2020 Q2	$169K	Buy	81,713 +16,213	+25%	+$32.8K	﹤0.01%	2187
2020 Q1	$88K	Buy	+65,500	New	+$214K	﹤0.01%	1796
2016 Q1	–	Sell	-46,000	Closed	-$136K	–	1622
2015 Q4	$136K	Buy	+46,000	New	+$127K	﹤0.01%	1339

Other funds holding CRHM

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

MRCM

Mill Road Capital Management Greenwich, Connecticut $191M AUM 56.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital's CRHM Position: Q1 2021 in Review

Arrowstreet Capital sold out of CRH Medical Corporation (CRHM) in Q1 2021, closing a stake of 153,388 shares — an estimated $357K sold.

Arrowstreet Capital first reported a position in CRHM in Q4 2015 and held it in 5 quarters. The position peaked at $411K in Q3 2020. 59 funds tracked by Wall St. Rank hold CRHM as of Q1 2021.

Arrowstreet Capital reported no remaining CRH Medical Corporation position as of Q1 2021 after selling out during the quarter.
Arrowstreet Capital sold 153,388 CRH Medical Corporation shares in Q1 2021, an estimated $357K.
Arrowstreet Capital first reported a position in CRH Medical Corporation in Q4 2015 and held it in 5 quarters.
Arrowstreet Capital's CRH Medical Corporation position peaked at $411K in Q3 2020.
59 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q1 2021.

Based on Arrowstreet Capital's 13F filing for Q1 2021, filed 14 May 2021.